T. Rowe Price Investment Management Increases Stake in BioLife Solutions to 13.5%

T. Rowe Price Investment Management, Inc. filed a Schedule 13G/A on May 15, 2026, disclosing a significant ownership stake in BioLife Solutions, Inc. (BLFS). As of the event date on March 31, 2026, the firm reported beneficial ownership of 6,506,346 shares of common stock, representing 13.5% of the company. This marks a substantial increase from the previously reported 0.0% ownership, indicating a new major position or a significant reporting adjustment. T. Rowe Price Investment Management holds sole voting and dispositive power over all reported shares. Within this holding, the T. Rowe Price Small-Cap Stock Fund specifically holds 2,562,102 shares, or 5.3% of the class. The filing was made under Rule 13d-1(b), certifying that the shares were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. The firm expressly denies beneficial ownership of these securities beyond its role as an investment adviser.